Skip to main navigation Skip to search Skip to main content

Caveolin-3 upregulation activates β-secretase-mediated cleavage of the amyloid precursor protein in Alzheimer's disease

  • Kazutoshi Nishiyama
  • , Bruce D. Trapp
  • , Tsuneya Ikezu
  • , Richard M. Ransohoff
  • , Taisuke Tomita
  • , Takeshi Iwatsubo
  • , Ichiro Kanazawa
  • , Karen K. Hsiao
  • , Michael P. Lisanti
  • , Takashi Okamoto

Research output: Contribution to journalArticlepeer-review

Abstract

Here, we investigate the involvement of caveolins in the pathophysiology of Alzheimer's disease (AD). We show dramatic upregulation of caveolin-3 immunoreactivity in astroglial cells surrounding senile plaques in brain tissue sections from authentic AD patients and an established transgenic mouse model of AD. In addition, we find that caveolin-3 physically interacts and biochemically colocalizes with amyloid precursor protein (APP) both in vivo and in vitro, interestingly, recombinant overexpression of caveolin-3 in cultured cells stimulated β-secretase-mediated processing of APP. Immunoreactivities of APP and presenilins were concomitantly increased in caveolin-3-positive astrocytes. Because the presenilins also form a physical complex with caveolin-3, caveolin-3 may provide a common platform for APP and the presenilins to associate in astrocytes. In AD, augmented expression of caveolin-3 and presenilins in reactive astrocytes may alter APP processing, leading to the overproduction of its toxic amyloid metabolites.

Original languageEnglish (US)
Pages (from-to)6538-6548
Number of pages11
JournalJournal of Neuroscience
Volume19
Issue number15
DOIs
StatePublished - Aug 1 1999

Keywords

  • Alzheimer's disease
  • Amyloid precursor protein
  • Astrocyte
  • Caveolin
  • Presenilin
  • Secretase

Fingerprint

Dive into the research topics of 'Caveolin-3 upregulation activates β-secretase-mediated cleavage of the amyloid precursor protein in Alzheimer's disease'. Together they form a unique fingerprint.

Cite this